510(k) · Cleared
ClearedConcentric Embolic Pearls
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Concentric Medical, Inc. · KRD Device, Vascular, For Promoting Embolization
Cleared on May 6, 2005 as substantially equivalent to K991549 (Biosphere Medical, 2000) and 3 other predicates after a 72-day review. Its family tree reaches back 3 generations to 1996.
- Decided
- May 6, 2005
- Review
- 72 days
- Class
- Class II
- Product code
- KRD
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 3 generations to K961923 (1996). 8 ancestors in all, the oldest K871047 (1987). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K961923 | Berenstein Coil | Target Therapeutics | 1996 | — |
| −2 | K964112 | Berenstein Coil | Target Therapeutics | 1997 | — |
| −1 | K991549 | Embosphere Microspheres | Biosphere Medical | 2000 | — |
| 0 (this device) | K050470 | Concentric Embolic Pearls | Concentric Medical, Inc. | 2005 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1987 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1997 | 1 | 0 |
| 2001 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KRD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KRD device
- #1 K253511 Concerto Versa™ Detachable Coilscore 17.6 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K991549 | Embosphere MicrospheresSummary page 1…earls are intended for use in the embolization of hypervascularized tumors in the peripheral vasculature. Predicate Devices EMBOSPHERE® Microspheres K991549 Manufactured by Biosphere Medical, Inc. EmboGoIdTM Microspheres K010026 Manufactured by Biosphere Medical,… | 2000 |
| * | K010026 | Embogold MicrosphereSummary page 1…asculature. Predicate Devices EMBOSPHERE® Microspheres K991549 Manufactured by Biosphere Medical, Inc. EmboGoIdTM Microspheres K010026 Manufactured by Biosphere Medical, Inc. TruFiIITM PVA Particles K951314, K965174 Manufactured by Cordis Endovas… | 2001 |
| * | K951314 | Truefill Pva ParticlesSummary page 1…ctured by Biosphere Medical, Inc. EmboGoIdTM Microspheres K010026 Manufactured by Biosphere Medical, Inc. TruFiIITM PVA Particles K951314, K965174 Manufactured by Cordis Endovascular Systems Device Description The Concentric Embolic Pearls are non-resorbable, hydrog… | 1995 |
| * | K965174 | Trufill Pva ParticlesSummary page 1…Biosphere Medical, Inc. EmboGoIdTM Microspheres K010026 Manufactured by Biosphere Medical, Inc. TruFiIITM PVA Particles K951314, K965174 Manufactured by Cordis Endovascular Systems Device Description The Concentric Embolic Pearls are non-resorbable, hydrogel-based… | 1997 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 3.2 years on median.
- None of the 8 ancestors has a recall.
- 6 other devices also cite its predicate K991549.
How does its category compare?
All KRD devicesKRD Device, Vascular, For Promoting Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KRD
9in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KRD
60in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KRD
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KRD
1,572in 2025
MAUDE reports naming product code KRD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 21 |
| 2008 | 5 | 84 | 0 | 14 |
| 2009 | 4 | 27 | 0 | 40 |
| 2010 | 3 | 150 | 1 | 61 |
| 2011 | 5 | 36 | 0 | 102 |
| 2012 | 8 | 30 | 0 | 137 |
| 2013 | 11 | 33 | 1 | 244 |
| 2014 | 7 | 134 | 0 | 159 |
| 2015 | 11 | 130 | 0 | 337 |
| 2016 | 4 | 164 | 0 | 437 |
| 2017 | 4 | 89 | 0 | 736 |
| 2018 | 4 | 62 | 0 | 1,066 |
| 2019 | 6 | 178 | 0 | 1,185 |
| 2020 | 4 | 137 | 0 | 1,167 |
| 2021 | 3 | 134 | 0 | 1,444 |
| 2022 | 8 | 175 | 0 | 1,498 |
| 2023 | 2 | — | 1 | 1,371 |
| 2024 | 6 | 70 | 1 | 1,535 |
| 2025 | 9 | 60 | 0 | 1,572 |
| 2026 | 7 | 70 | 1 | — |
What is it indicated for?
The Concentric Embolic Pearls are indicated for use in the embolization of hypervascularized tumors in the peripheral vasculature.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K050470 · printed Nov 6, 2026
Cite this page
510(k) Report. “K050470: Concentric Embolic Pearls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K050470
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026